Penicillin G 800mg Tablet Franchise in Ahmedabad

Beta-Lactam Antibiotic Supplier in Mumbai

Penlink 800 Tablet Distributor in Delhi

Bacterial Infection Treatment Tablet Franchise Opportunity in Bangalore

Oral Antibiotic Tablet Stockist in Hyderabad
Penicillin G 800mg Export & Manufacturing in Chandigarh

Home/Products /penicillin-g-800mg-tablet

Penlink 800 Tablet

Composition : Penicillin G (800mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Strip

Packaging : 10*10

Price : ₹1/-

Penlink 800 Tablet contains Penicillin G 800mg, a potent beta-lactam antibiotic indicated for the treatment of infections caused by susceptible gram-positive and selected gram-negative bacteria. It helps in controlling respiratory tract infections, skin and soft tissue infections, and other bacterial illnesses effectively.

Penicillin G works by inhibiting bacterial cell wall synthesis, leading to bacterial cell death and rapid infection control. Its oral tablet formulation ensures convenient administration while maintaining reliable antibacterial activity.

For distributors and healthcare suppliers, Penlink 800 Tablet is a high-demand antibacterial therapy product, commonly used in hospitals, clinics, and community healthcare facilities. The consistent need for effective antibiotics ensures stable year-round demand.

Adding Penlink 800 Tablet to your oral antibacterial and anti-infective therapy segment creates strong opportunities in pharmacies, hospitals, clinics, export markets, and third-party manufacturing. Its trusted efficacy, prescriber confidence, and broad therapeutic application make it a valuable addition to pharmaceutical distribution portfolios.

Read More

About the Product

Penlink 800 Tablet contains Penicillin G 800mg, a potent beta-lactam antibiotic indicated for the treatment of infections caused by susceptible gram-positive and selected gram-negative bacteria. It helps in controlling respiratory tract infections, skin and soft tissue infections, and other bacterial illnesses effectively.

Penicillin G works by inhibiting bacterial cell wall synthesis, leading to bacterial cell death and rapid infection control. Its oral tablet formulation ensures convenient administration while maintaining reliable antibacterial activity.

For distributors and healthcare suppliers, Penlink 800 Tablet is a high-demand antibacterial therapy product, commonly used in hospitals, clinics, and community healthcare facilities. The consistent need for effective antibiotics ensures stable year-round demand.

Adding Penlink 800 Tablet to your oral antibacterial and anti-infective therapy segment creates strong opportunities in pharmacies, hospitals, clinics, export markets, and third-party manufacturing. Its trusted efficacy, prescriber confidence, and broad therapeutic application make it a valuable addition to pharmaceutical distribution portfolios.

Common side effects may include nausea, vomiting, diarrhea, or mild skin rash. Rare but serious side effects include severe allergic reactions such as anaphylaxis, angioedema, or serum sickness. Immediate medical attention should be sought if severe hypersensitivity occurs.

Penlink 800 Tablet is indicated for the treatment of moderate to severe infections such as respiratory tract infections, skin and soft tissue infections, ENT infections, dental infections, and other bacterial infections caused by penicillin-sensitive organisms, as prescribed by a healthcare professional.

Penlink 800 Tablet should be taken exactly as prescribed, and the full course must be completed to ensure effective treatment and prevent antibiotic resistance. Patients with a known allergy to penicillins or cephalosporins should inform their doctor before use. Dose adjustments may be necessary in patients with kidney impairment.

Store Penlink 800 Tablet in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children and do not use the tablet beyond the expiry date printed on the packaging.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation